Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation

BACKGROUND: Mesenchymal stem cells (MSCs) have become a promising candidate for cell-based immune therapy for acute rejection (AR) after heart transplantation due to possessing immunomodulatory properties. In this study, we evaluated the efficacy of soluble fibronectin-like protein 2 (sFgl2) overexp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Res Ther
Autori principali: Gao, Chao, Wang, Xiaodong, Lu, Jian, Li, Zhilin, Jia, Haowen, Chen, Minghao, Chang, Yuchen, Liu, Yanhong, Li, Peiyuan, Zhang, Baotong, Du, Xuezhi, Qi, Feng
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301524/
https://ncbi.nlm.nih.gov/pubmed/32552823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01752-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi